Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Musculoskeletal Disorders

Open Access

Molecular diagnosis and next generation gene sequencing in neuromuscular clinical practice

  • Silvère van der Maarel1
BMC Musculoskeletal Disorders201314(Suppl 2):O6

https://doi.org/10.1186/1471-2474-14-S2-O6

Published: 29 May 2013

Next generation sequencing (NGS) is revolutionizing the way we do research on genetic disorders. While earlier DNA sequencing was often the last step in disease gene discovery, nowadays it is becoming the starting point. Also, in the diagnostic setting, NGS is gaining momentum and is rapidly being implemented in laboratories around the world. With new developments trending toward more cost effective (label-free) technologies and higher throughput and fidelity, NGS instrumentation will undoubtedly become the gold standard. However, NGS in diagnostic and research settings will also impose new technical and computational challenges upon us, and raise ethical issues that will need to be addressed. Here I will discuss various NGS technologies and their specific characteristics and applications, with emphasis on translational research, bringing gene discovery into the diagnostic setting, and implications for the diagnosis of Pompe disease.

Authors’ Affiliations

(1)
Department of Human Genetics, Leiden University Medical Center

Copyright

© van der Maarel; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement